Kenneth Hoberman
2013
In 2013, Kenneth Hoberman earned a total compensation of $835.4K as Chief Operating Officer at Stemline Therapeutics, a 195% increase compared to previous year.
Compensation breakdown
| Bonus | $187,500 |
|---|---|
| Non-Equity Incentive Plan | $283,366 |
| Salary | $364,583 |
| Total | $835,449 |
Hoberman received $364.6K in salary, accounting for 44% of the total pay in 2013.
Hoberman also received $187.5K in bonus and $283.4K in non-equity incentive plan.
Rankings
In 2013, Kenneth Hoberman's compensation ranked 7,414th out of 12,286 executives tracked by ExecPay. In other words, Hoberman earned more than 39.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,414 out of 12,286 | 40th |
Division Manufacturing | 2,664 out of 4,612 | 42nd |
Major group Chemicals And Allied Products | 831 out of 1,462 | 43rd |
Industry group Drugs | 623 out of 1,156 | 46th |
Industry Pharmaceutical Preparations | 493 out of 890 | 45th |
Source: SEC filing on April 8, 2016.
Hoberman's colleagues
We found four more compensation records of executives who worked with Kenneth Hoberman at Stemline Therapeutics in 2013.